Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Suppression of mTOR Signaling by miR-302/367 Cluster in Breast Cancer Cells
Mahsa Alemi1, Masoumeh Fakhr Taha1, Arezoo Bazargani1
1Department of Stem Cells and Regenerative Medicine, Institute for Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Abstract:
The mTOR signaling pathway is central in regulating key cellular functions, including cell cycle progression, protein synthesis, and glucose metabolism. Dysregulation of this pathway is a hallmark of many cancers. We previously demonstrated the multimodal tumor suppressive effects of the miR-302/367 cluster. In this investigation, we explored the effects of exogenous overexpression of the miR-302/367 cluster on mTOR signaling in malignant cells and assessed its direct targeting of pathway components. Bioinformatic analyses revealed PIK3CB, RRAGD, FNIP1, and FNIP2 as potential targets of miR-302/367 involved in mTOR regulation. Dual-luciferase reporter assays validated the direct interaction between the miR-302/367 cluster with PIK3CB, RRAGD, and FNIP1. Transfection of SK-BR-3 and MDA-MB-231 breast cancer cell lines with a vector expressing miR-302/367 resulted in the downregulation of these three genes at the transcript level. Furthermore, the protein levels of FNIP1, RRAGD, and PIK3CB were also diminished in both cell lines. Additionally, cell proliferation was inhibited, and profiling of gene and protein expression indicated a downregulation of several other components of the mTOR pathway, suggesting a broad inhibitory effect of miR-302/367 on mTOR signaling. These results reveal a novel molecular mechanism by which the miR-302/367 cluster may exert tumor-suppressive effects by modulating mTOR pathway activity at multiple levels in breast cancer cells, thereby suggesting its potential relevance for future therapeutic investigation in cancer treatment.
Insights
The miR-302/367 cluster suppresses tumors by inhibiting the mTOR pathway in breast cancer cells. This microRNA cluster targets key mTOR regulators, reducing their expression and slowing cancer cell growth.
Area of Science:
- Molecular biology
- Cancer research
- Biochemistry
Background:
- The mechanistic target of rapamycin (mTOR) signaling pathway regulates critical cellular processes like protein synthesis and metabolism.
- Aberrant mTOR signaling is frequently observed in various cancers.
- The miR-302/367 microRNA cluster has demonstrated tumor-suppressive properties.
Purpose of the Study:
- To investigate the impact of miR-302/367 cluster overexpression on mTOR signaling in cancer cells.
- To identify and validate direct targets of miR-302/367 within the mTOR pathway.
- To elucidate the molecular mechanisms underlying the tumor-suppressive effects of miR-302/367.
Main Methods:
- Bioinformatic analysis to predict miR-302/367 targets in the mTOR pathway.
- Dual-luciferase reporter assays to confirm direct targeting of PIK3CB, RRAGD, and FNIP1.
- Gene and protein expression analysis in breast cancer cell lines (SK-BR-3, MDA-MB-231) after miR-302/367 transfection.
- Cell proliferation assays.
Main Results:
- PIK3CB, RRAGD, and FNIP1 were validated as direct targets of the miR-302/367 cluster.
- Overexpression of miR-302/367 led to decreased transcript and protein levels of PIK3CB, RRAGD, and FNIP1.
- miR-302/367 transfection inhibited breast cancer cell proliferation.
- Downregulation of multiple mTOR pathway components was observed, indicating a broad inhibitory effect.
Conclusions:
- The miR-302/367 cluster exerts tumor-suppressive effects in breast cancer by modulating mTOR signaling at multiple levels.
- This microRNA cluster directly targets key components of the mTOR pathway, including PIK3CB, RRAGD, and FNIP1.
- The findings suggest therapeutic potential for the miR-302/367 cluster in cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

